{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/whooping-cough/prescribing-information/azithromycin/","result":{"pageContext":{"chapter":{"id":"69df3991-1f78-5988-a277-eba775516ffc","slug":"azithromycin","fullItemName":"Azithromycin","depth":2,"htmlHeader":"<!-- begin field 5bc92c58-1a7e-4dec-a219-31b988a96692 --><h2>Azithromycin</h2><!-- end field 5bc92c58-1a7e-4dec-a219-31b988a96692 -->","summary":"","htmlStringContent":"<!-- begin item 8356f9be-d68a-4c56-a418-62969fa612d1 --><!-- end item 8356f9be-d68a-4c56-a418-62969fa612d1 -->","topic":{"id":"35659c4f-d80b-5e8b-8b62-22146482d6da","topicId":"aa36f776-3bec-44aa-ba6f-c147b57f7328","topicName":"Whooping cough","slug":"whooping-cough","lastRevised":"Last revised in January 2021","chapters":[{"id":"57f71ac2-7f00-5c54-b9dc-d2d7d9425e4f","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"43ee7c18-a7d1-5aaf-b7b1-e9f8aec21522","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"c127e190-a190-5b44-9ef6-9f30b6527b35","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"86a8dc5e-4401-57e4-a893-30e9405e7e8d","slug":"changes","fullItemName":"Changes"},{"id":"f0e375ca-3710-5454-996c-600b6987bc09","slug":"update","fullItemName":"Update"}]},{"id":"9165fc1a-9d30-5e58-9bb2-a1b68eab43c6","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"39a4fa70-e2db-566b-9c9e-0be39b8be0ac","slug":"goals","fullItemName":"Goals"},{"id":"7fd8bab1-ed01-583f-925f-50b956b1065b","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"4c330a84-fe34-5261-acf3-bcd6c9b9d2ef","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"dab08320-4d0b-59e9-b25a-28f9cc15908b","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a088fcbf-b960-56c1-a102-2cb980dc3cb0","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"05a22688-4243-5ec9-814d-874c82306da6","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"32d067f6-839d-500a-9f89-494e3487c3fd","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"76a32750-044c-5bf9-b055-60be74d61d05","slug":"definition","fullItemName":"Definition"},{"id":"ba541f69-d5c7-5bfb-bcef-ec03ceaceee7","slug":"prevalence","fullItemName":"Prevalence"},{"id":"5d07a89e-bdd9-5e79-81eb-87c32d271af2","slug":"prognosis","fullItemName":"Prognosis"},{"id":"054c3198-af7f-5c25-8611-2cc61ad8a848","slug":"complications","fullItemName":"Complications"}]},{"id":"41fa1350-a42e-56da-b04d-aba216545b35","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"6eb9d7f5-32ca-5aaa-b5f3-1ac34aeff0d6","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"02ae0369-3f8d-5a31-b677-d0a1d5d0e6f9","slug":"making-a-clinical-diagnosis","fullItemName":"Making a clinical diagnosis"},{"id":"0a55b0ed-e1e6-5bf2-a57c-ec4bda345338","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"},{"id":"95029ae8-217f-53b1-b552-1b19a63a1460","slug":"notification-confirmation","fullItemName":"Notification and confirmation"}]},{"id":"e9f5a777-75d4-5e44-9222-d0679a35b79f","fullItemName":"Management","slug":"management","subChapters":[{"id":"be786901-8aa4-5cf6-977f-07c667507f85","slug":"management-of-whooping-cough","fullItemName":"Scenario: Management of whooping cough"}]},{"id":"73184dce-2f33-555a-99f5-1f7676165d85","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"c6240279-15ed-57da-bbbc-a009ed1fe10d","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"f55a7bd1-232f-5264-b591-1615754d7cd4","slug":"erythromycin","fullItemName":"Erythromycin"},{"id":"69df3991-1f78-5988-a277-eba775516ffc","slug":"azithromycin","fullItemName":"Azithromycin"},{"id":"83991d80-1c24-5213-80d8-d98f94f7165f","slug":"co-trimoxazole","fullItemName":"Co-trimoxazole"},{"id":"9e55dced-d32c-53b0-9767-ec433fb86549","slug":"paracetamol","fullItemName":"Paracetamol"},{"id":"6a290b31-ff8d-56f2-aa28-4f7fc47c5ff6","slug":"ibuprofen","fullItemName":"Ibuprofen"}]},{"id":"0cb3e998-9c97-56e6-86e8-373f09a16cee","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"06233f93-f6af-5a86-a0d3-f66b18e22f6f","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"933608bb-6634-5ada-9704-c47966180200","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"b65931da-6bf7-5353-a3e6-b7b3f0da241d","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"9e63923e-f250-5bb8-b436-8c4426b094d4","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"8a644bf0-15a8-56ea-a310-b3625c09b8ce","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"4da49df8-81c2-588b-aaf2-014b7ddf9181","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"20d6c374-e4e4-55e9-8247-f63253537476","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"73184dce-2f33-555a-99f5-1f7676165d85","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"35b94910-d765-502e-8800-b860c22b6738","slug":"dose","fullItemName":"Dose","depth":3,"htmlHeader":"<!-- begin field 79980ed4-1d1f-4930-aeaa-bb74be9e0ba5 --><h3>Dosing information</h3><!-- end field 79980ed4-1d1f-4930-aeaa-bb74be9e0ba5 -->","summary":"","htmlStringContent":"<!-- begin item 03740c4f-639f-436e-bec5-b1b5623ffb87 --><!-- begin field 4b2eaabe-5d9b-4ad3-9a20-49e5505e556a --><ul><li><strong>In neonates, infants, and children, </strong>prescribe 10 mg/kg (to a maximum of 500 mg) once a day for 3 days.</li><li><strong>In adults, </strong>prescribe 500 mg once a day for 3 days.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">BNF 72, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">PHE, 2016b</a>]</p><!-- end field 4b2eaabe-5d9b-4ad3-9a20-49e5505e556a --><!-- end item 03740c4f-639f-436e-bec5-b1b5623ffb87 -->","subChapters":[]},{"id":"1e0bdf0f-65fe-557c-adfb-3cf74309a1ac","slug":"contraindications-cautions","fullItemName":"Contraindications and cautions","depth":3,"htmlHeader":"<!-- begin field ac648660-c8fb-419f-b230-4bcc2d58043b --><h3>Contraindications and cautions</h3><!-- end field ac648660-c8fb-419f-b230-4bcc2d58043b -->","summary":"","htmlStringContent":"<!-- begin item bf4b7cea-74a5-4efa-9fbe-ab829245fa81 --><!-- begin field d91d996e-ea01-4bc0-a3f9-4ae47c137c51 --><p><strong>Do not prescribe azithromycin </strong><strong>to people:</strong></p><ul><li>With severe hepatic impairment.</li><li>Taking drugs that prolong the QT interval (for example amiodarone, sotalol, terfenadine, and amisulpride) — macrolides can also prolong the QT interval, which is a risk factor for Torsades de pointes.</li><li>With hypokalaemia, due to the risk of prolongation of the QT interval.</li><li>With a history of QT prolongation or ventricular cardiac arrhythmia, including Torsades de pointes.</li></ul><p><strong>Prescribe azithromycin with caution </strong><strong>to people with:</strong></p><ul><li>Mild to moderate hepatic impairment.</li><li>Moderate to severe renal impairment.</li><li>Myasthenia gravis — macrolides may aggravate weakness symptoms.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">ABPI, 2016c</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">BNF 72, 2016</a>]</p><!-- end field d91d996e-ea01-4bc0-a3f9-4ae47c137c51 --><!-- end item bf4b7cea-74a5-4efa-9fbe-ab829245fa81 -->","subChapters":[]},{"id":"ac60d5b7-df9b-571a-a2fa-6147347f3982","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field 4b16519c-5449-49e8-a5a8-68add71eacd1 --><h3>Adverse effects</h3><!-- end field 4b16519c-5449-49e8-a5a8-68add71eacd1 -->","summary":"","htmlStringContent":"<!-- begin item 04a5aaef-a4e5-4f7c-bc4f-fb0b866887f5 --><!-- begin field 9ae9a64e-fa52-40e9-956d-c57bb436b17d --><ul><li><strong>Nausea, vomiting, abdominal discomfort, and diarrhoea </strong>are the most common adverse effects of macrolides, but they are milder and less frequent with azithromycin than with erythromycin.</li><li><strong>Consider pseudomembranous colitis </strong>if a person develops severe diarrhoea during or after treatment with azithromycin.<ul><li>Pseudomembranous colitis is an acute, exudative colitis caused by <em>Clostridium difficile</em>, a Gram-positive toxin-releasing bacillus. It often follows antibiotic treatment. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/diarrhoea-antibiotic-associated/\">Diarrhoea - antibiotic associated</a>.</li></ul></li><li><strong>Anaphylaxis </strong>is rarely associated with azithromycin.</li><li><strong>Hepatotoxicity (including cholestatic jaundice) and rash </strong>have been reported following treatment with azithromycin.</li><li><strong>Other adverse effects reported rarely or very rarely include </strong>pancreatitis, QT interval prolongation, arrhythmias, Stevens-Johnson syndrome, and toxic epidermal necrolysis.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">ABPI, 2016c</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">BNF 72, 2016</a>]</p><!-- end field 9ae9a64e-fa52-40e9-956d-c57bb436b17d --><!-- end item 04a5aaef-a4e5-4f7c-bc4f-fb0b866887f5 -->","subChapters":[]},{"id":"6433f744-2ce7-56b3-b8b6-649840e99d9c","slug":"drug-interactions","fullItemName":"Drug interactions","depth":3,"htmlHeader":"<!-- begin field 67aebd20-6502-4aea-a888-6a8fd2b33886 --><h3>Drug interactions</h3><!-- end field 67aebd20-6502-4aea-a888-6a8fd2b33886 -->","summary":"","htmlStringContent":"<!-- begin item f310d83e-9cf7-432f-91ea-1d9432e65306 --><!-- begin field 7297bc61-8b61-4245-ab0e-38c01c094e22 --><ul><li><strong>Warfarin — </strong>occasionally and unpredictably, the effects of warfarin may be markedly increased by macrolides.<ul><li>Monitor the international normalized ratio (INR), and adjust the warfarin dose accordingly.</li></ul></li><li><strong>Statins — </strong>the manufacturer reports post-marketing cases of rhabdomyolysis in people taking azithromycin with statins, although this appears to be less common than with other macrolides.<ul><li>Advise the person to report any muscle pain, tenderness, or weakness.</li></ul></li><li><strong>Ciclosporin </strong>— azithromycin can affect clearance of ciclosporin. If co-administration of these drugs is necessary, ciclosporin levels should be monitored and the dose adjusted accordingly.</li><li><strong>Drugs that prolong the QT interval </strong>(such as amiodarone, sotalol, terfenadine, and amisulpride) — all macrolides can prolong the QT interval, and concomitant use of drugs that prolong the QT interval is not recommended.<ul><li>Seek advice from a microbiologist regarding a suitable alternative antibiotic.</li></ul></li><li><strong>Drugs that cause hypokalaemia </strong>(such as diuretics, corticosteroids, short-acting beta<sub>2</sub>-agonists) — hypokalaemia is a risk factor for QT prolongation.<ul><li>Seek advice from a microbiologist regarding a suitable alternative antibiotic.</li></ul></li><li><strong>Colchicine </strong>—  concomitant administration has been reported to increase levels of P-glycoprotein substrate. This protein has been linked to barriers to successful chemotherapy treatment in cancer.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">ABPI, 2016c</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">BNF 72, 2016</a>]</p><!-- end field 7297bc61-8b61-4245-ab0e-38c01c094e22 --><!-- end item f310d83e-9cf7-432f-91ea-1d9432e65306 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}